Oral Malignant Melanomas and Other Head and Neck Neoplasms in Danish Dogs--data from the Danish Veterinary Cancer Registry

Overview

Journal Acta Vet Scand

Publisher Biomed Central

Specialty Veterinary Medicine

Date 2009 Dec 22

PMID 20021647

Citations 12

Authors

Louise B Bronden

Thomas Eriksen

Annemarie T Kristensen

Affiliations

Soon will be listed here.

Abstract

Background: Head and neck cancers (HNC) are relatively common and often very serious diseases in both dogs and humans. Neoplasms originating in the head and neck region are a heterogeneous group. HNC often has an unfavourable prognosis and the proximity of the tissue structures renders extirpation of tumours with sufficient margins almost incompatible with preservation of functionality. In humans oral malignant melanoma (OMM) is extremely rare, but represents a particular challenge since it is highly aggressive as is the canine counterpart, which thus may be of interest as a spontaneous animal model.

Methods: Canine cases entered in the Danish Veterinary Cancer Registry (DVCR) from May 15th 2005 through February 29th 2008 were included in this study. Fisher's exact test was used to compare proportions of HNC in dogs and humans as well as proportions of surgically treated cases of OMM and squamous cell carcinomas (SCC). Also the proportions of benign and malignant neoplasms of different locations in dogs were compared using Fisher's exact test.

Results: A total of 1768 cases of neoplasias (679 malignant, 826 benign, 263 unknown) were submitted. Of all neoplasias HNC accounted for 7.2% (n = 128). Of these, 64 (50%) were malignant and 44 (34%) benign. The most common types of malignant neoplasia were SCC (18; 28% of malignant), OMM (13; 20% of malignant), soft tissue sarcoma (11; 17% of malignant) and adenocarcinoma (5; 11% of malignant). The most common types of benign neoplasms were adenoma (7; 16% of benign), polyps (6; 14% of benign) and fibroma (5; 11% of benign).

Conclusions: In the current study, the proportion of neoplasia in the head and neck region in dogs in Denmark was similar to other canine studies and significantly more common than in humans with a large proportion of malignancies. Spontaneous HNC in dogs thus, may serve as a model for HNC in humans.Canine OMM is a spontaneous cancer in an outbred, immune-competent large mammal population and could be a clinical model for OMM in humans.

Citing Articles

Risk stratification scheme based on the TNM staging system for dogs with oral malignant melanoma centered on clinicopathologic presentation.

Song E, Lawrence J, Greene E, Christie A, Goldschmidt S Front Vet Sci. 2024; 11:1472748.

PMID: 39386252 PMC: 11463030. DOI: 10.3389/fvets.2024.1472748.

Characteristics of canine oral tumors: Insights into prevalence, types, and lesion distribution.

Satthathum C, Srisampane S, Jariyarangsrirattana P, Anusorn P, Sattasathuchana P, Thengchaisri N J Adv Vet Anim Res. 2023; 10(3):554-562.

PMID: 37969809 PMC: 10636079. DOI: 10.5455/javar.2023.j709.

Isolation of Oral Bacteria, Measurement of the C-Reactive Protein, and Blood Clinical Parameters in Dogs with Oral Tumor.

Setthawongsin C, Khunbutsri D, Pisamai S, Raksajit W, Ngamkala S, Jarudecha T Vet Med Int. 2023; 2023:2582774.

PMID: 37009523 PMC: 10060073. DOI: 10.1155/2023/2582774.

Employing deep convolutional neural networks for segmenting the medial retropharyngeal lymph nodes in CT studies of dogs.

Schmid D, Scholz V, Kircher P, Lautenschlaeger I Vet Radiol Ultrasound. 2022; 63(6):763-770.

PMID: 35877815 PMC: 9796347. DOI: 10.1111/vru.13132.

Deep-Learning-Based Automatic Segmentation of Head and Neck Organs for Radiation Therapy in Dogs.

Park J, Choi B, Ko J, Chun J, Park I, Lee J Front Vet Sci. 2021; 8:721612.

PMID: 34552975 PMC: 8450455. DOI: 10.3389/fvets.2021.721612.

References

Meler E, Dunn M, Lecuyer M . A retrospective study of canine persistent nasal disease: 80 cases (1998-2003). Can Vet J. 2008; 49(1):71-6. PMC: 2147700. View

Arnesen K, Gamlem H, Glattre E, Moe L, Nordstoga K . [Registration of canine cancer]. Tidsskr Nor Laegeforen. 1995; 115(6):714-7. View

Bergman P, McKnight J, Novosad A, Charney S, Farrelly J, Craft D . Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin Cancer Res. 2003; 9(4):1284-90. View

Meleti M, Leemans C, Mooi W, Vescovi P, van der Waal I . Oral malignant melanoma: a review of the literature. Oral Oncol. 2006; 43(2):116-21. DOI: 10.1016/j.oraloncology.2006.04.001. View

Ramos-Vara J, Beissenherz M, Miller M, Johnson G, Pace L, Fard A . Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol. 2000; 37(6):597-608. DOI: 10.1354/vp.37-6-597. View

Bastianello S . A survey on neoplasia in domestic species over a 40-year period from 1935 to 1974 in the Republic of South Africa. VI. Tumours occurring in dogs. Onderstepoort J Vet Res. 1983; 50(3):199-220. View

Reif J, Cohen D . The environmental distribution of canine respiratory tract neoplasms. Arch Environ Health. 1971; 22(1):136-40. DOI: 10.1080/00039896.1971.10665823. View

King G, Bergman P, Harris D . Radiation oncology of head and neck tumors. Vet Clin North Am Small Anim Pract. 1997; 27(1):101-13. DOI: 10.1016/s0195-5616(97)50009-x. View

Bergman P . Anticancer vaccines. Vet Clin North Am Small Anim Pract. 2007; 37(6):1111-9. DOI: 10.1016/j.cvsm.2007.06.005. View

10.

Knapp D, Waters D . Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans. Mol Med Today. 1997; 3(1):8-11. DOI: 10.1016/s1357-4310(96)20031-0. View

11.

Garbe P . The companion animal as a sentinel for environmentally related human diseases. Acta Vet Scand Suppl. 1988; 84:290-2. View

12.

Sortino-Rachou A, de Camargo Cancela M, Voti L, Curado M . Primary oral melanoma: population-based incidence. Oral Oncol. 2008; 45(3):254-8. DOI: 10.1016/j.oraloncology.2008.04.015. View

13.

Collen E, Mayer M . Acute oropharyngeal effects of full-course radiation treatment of tumors of the head. Can Vet J. 2008; 49(5):509-12. PMC: 2359501. View

14.

Merlo D, Rossi L, Pellegrino C, Ceppi M, Cardellino U, Capurro C . Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy. J Vet Intern Med. 2008; 22(4):976-84. DOI: 10.1111/j.1939-1676.2008.0133.x. View

15.

Bronden L, Lindstrand S, Nielsen S, Toft N, Kristensen A . Validation of data collected in the Danish Veterinary Cancer Registry. Vet Comp Oncol. 2009; 7(3):207-11. DOI: 10.1111/j.1476-5829.2009.00191.x. View

16.

Kirkwood J, Lee S, Moschos S, Albertini M, Michalak J, Sander C . Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696. Clin Cancer Res. 2009; 15(4):1443-51. PMC: 2759898. DOI: 10.1158/1078-0432.CCR-08-1231. View

17.

Vail D, MacEwen E . Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 2000; 18(8):781-92. DOI: 10.3109/07357900009012210. View

18.

DORN C, Taylor D, Schneider R, Hibbard H, Klauber M . Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst. 1968; 40(2):307-18. View

19.

Glickman L, Schofer F, McKee L, Reif J, Goldschmidt M . Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs. J Toxicol Environ Health. 1989; 28(4):407-14. DOI: 10.1080/15287398909531360. View

20.

Carvalho A, Nishimoto I, Califano J, Kowalski L . Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2004; 114(5):806-16. DOI: 10.1002/ijc.20740. View